Thistle Mary
Insider CIK 1317917 · ZIOP Director · DMTX Chief Operating Officer · FIXX Director · TRDA Director · CGEM Director · VIGL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2026-06-16 | 2026-06-18 | 25,319 | — | $0 | 25,319 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-07-21 | 10,826 | — | $0 | 10,826 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 9,810 | — | $0 | 9,810 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-10-23 | 2025-10-27 | 53,521 | — | $0 | 53,521 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 24,309 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 18,068 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 5,000 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award | 2025-05-22 | 2025-05-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 12,767 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 12,767 | — | $0 | 12,767 | SEC↗ |
| CGEM Cullinan Therapeutics, Inc | A Award deriv | 2024-08-08 | 2024-08-09 | 25,743 | — | $0 | 25,743 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 18,068 | — | $0 | 18,068 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 24,309 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 24,309 | — | $0 | 24,309 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 12,155 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 13,928 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 12,767 | — | $0 | 12,767 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 23,000 | — | $0 | 23,000 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 13,928 | — | $0 | 13,928 | SEC↗ |
| TCRT Alaunos Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TCRT Alaunos Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TCRT Alaunos Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TCRT Alaunos Therapeutics, Inc. | A Award | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 45,000 | SEC↗ |
| TCRT Alaunos Therapeutics, Inc. | A Award | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 45,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 12,155 | — | $0 | 12,155 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 11,918 | — | $0 | 11,918 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-04-18 | 2022-04-20 | 24,309 | — | $0 | 24,309 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 11,918 | — | $0 | 11,918 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2021-03-04 | 2021-05-06 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2021-03-04 | 2021-05-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award | 2021-03-04 | 2021-05-06 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 15,580 | — | $0 | 15,580 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2018-03-27 | 2018-03-29 | 31,160 | — | $0 | 31,160 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 60,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 27,711 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 65,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 17,104 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 180,815 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-02-01 | 2017-02-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-02-01 | 2016-02-02 | 65,000 | — | $0 | 65,000 | SEC↗ |